DOST-PCHRD to support 3 Filipino startups for health R&D

DOST-PCHRD to support 3 Filipino startups for health R&D
LH2: This DOST-FNRI drying system helps retain nutritional, sensory properties of fruits, vegetables
The project entitled “The Beneficial Effects of Virgin Coconut Oil among Suspect and Probable Cases of COVID-19,” led by Dr. Imelda Angeles-Agdeppa of DOST-FNRI, conducted a community trial in Sta. Rosa City that evaluated the effects of VCO as an adjunct supplement for COVID-19 by mixing VCO into the cooked meals of suspect and probable COVID-19 cases.
The Department of Science and Technology (DOST) and the Department of Health (DOH) will support a research which will look into the possibility of mixing and matching different COVID-19 vaccine brands and platforms through a study involving 3,000 Filipino participants starting June 2021.
Results of state-funded clinical trials on virgin coconut oil (VCO) in Santa Rosa, Laguna, which showed it was an effective “functional food” to help treat probable and suspect cases of COVID-19, has been published in an international journal.
The Department of Science and Technology (DOST) urged Saturday, May 22, those Filipino scientists who were trained abroad to come back and work with the agency, citing that its Balik Scientist Program (BSP) “is more than prepared” to assist them.
Consume more fruits and drink plenty of water to avoid getting dehydrated as the country is currently experiencing very high temperatures. This was the reminder of DOH—Calabarzon Regional Director Eduardo C. Janairo as the country has been experiencing very hot and humid weather the past few days.
DOST Secretary Fortunato de la Peña provided updates on some COVID-19 projects for diagnostics, public health surveillance and therapeutics supported by the DOST – Philippine Council for Health Research and Development (DOST-PCHRD)
Mindanao scientists are now in anticipation of the first research center to be established in the region aimed to strengthen local response to infectious diseases, including COVID-19.